Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a Multi-Pathway Topical Therapy (G21) in a 12-Month Observational Study.

Adamidis N, Adamidi S, Georgakopoulou VE, Adamidis S

Open source

DOI
10.7759/cureus.107073
Published
2026 Apr
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.107073,
  title = {Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a Multi-Pathway Topical Therapy (G21) in a 12-Month Observational Study.},
  author = {Adamidis N and Adamidi S and Georgakopoulou VE and Adamidis S},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.107073},
  url = {https://doi.org/10.7759/cureus.107073}
}

RIS

TY  - JOUR
TI  - Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a Multi-Pathway Topical Therapy (G21) in a 12-Month Observational Study.
AU  - Adamidis N
AU  - Adamidi S
AU  - Georgakopoulou VE
AU  - Adamidis S
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.107073
UR  - https://doi.org/10.7759/cureus.107073
ER  - 

APA

N, A., S, A., VE, G., & S, A. (2026). Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a Multi-Pathway Topical Therapy (G21) in a 12-Month Observational Study.. Cureus. https://doi.org/10.7759/cureus.107073

Source records